Skip to main content
. 2014 Jun 28;18(8):1655–1666. doi: 10.1111/jcmm.12352

Table 2.

TMEM106A methylation status and Clinicopathological characteristics in gastric cancer

TMEM106A methylation status

Clinicopathological parameters n Methylated n = 93 (88.6%) Unmethylated n = 12 (11.4%) P-value
Age (years)
 <50 20 17 (85%) 3 (15%) 0.5787
 ≥50 85 76 (89.4%) 9 (10.6%)
Gender
 Male 77 69 (89.6%) 8 (10.4%) 0.5808
 Female 28 24 (85.7%) 4 (14.3%)
Alcohol abuse
 Negative 75 68 (90.7%) 7 (9.3%) 0.2883
 Positive 30 25 (83.3%) 5 (16.7%)
Smoking
 Negative 71 66 (93.0%) 5 (7.0%) 0.0422*
 Positive 34 27 (79.4%) 7 (20.6%)
Differentiation
 Poor/Moderate 95 84 (88.4%) 11 (11.67%) 0.5337
 Well 3 3 (100.0%) 0 (0.0%)
T
 T2/T3 7 7 (100.0%) 0 (0.0%) 0.3276
 T4 98 86 (87.8%) 12 (12.2%)
N
 N0 17 13 (76.5%) 4 (23.5%) 0.0882
 N1/N2/N3 88 80 (90.9%) 8 (9.1%)
M
 M0 81 69 (85.2%) 12 (14.8%) 0.0462*
 M1 24 24 (100.0%) 0 (0.0%)
TNM Stage
 II/III 84 72 (85.7%) 12 (14.3%) 0.0670
 IV 21 21 (100.0%) 0 (0.0%)
*

P < 0.05.